InCarda Therapeutics

    OverviewSuggest Edit

    InCarda Therapeutics is a biopharmaceutical company researching an approach to treat cardiovascular diseases and conditions by the inhalation route. It develops an inhaled therapy to deliver flecainide to the heart via the lungs to treat a common atrial arrhythmia and paroxysmal atrial fibrillation.
    TypePrivate
    Founded2009
    Websiteincardatherapeutics.com

    Latest Updates

    Employees (est.) (Mar 2020)19

    InCarda Therapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    2009

    InCarda Therapeutics latest funding size

    $5 m

    InCarda Therapeutics investors

    Show all financial metrics

    InCarda Therapeutics Online and Social Media Presence

    Embed Graph

    InCarda Therapeutics Frequently Asked Questions

    • When was InCarda Therapeutics founded?

      InCarda Therapeutics was founded in 2009.

    • How many employees does InCarda Therapeutics have?

      InCarda Therapeutics has 19 employees.

    • Who are InCarda Therapeutics competitors?

      Competitors of InCarda Therapeutics include Urovant Sciences, Abiogen Pharma and Bellerophon Therapeutics.